|
Symbol
|
RMALXV | RMAQ1V | NUHRCH | RMADXV | RMAG6V | HZWEFG | KYCYDU | KYCUDU | RMAZKV | RMAUGV | OJSRCH | RMA23V | KYGDDU | KYFWDU | AAAHTQ | KYHHDU | KYDNDU | RMA7AV | AAHKTQ | OMFRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N / UBS Group AG | Julius Baer Group / Partners Group Hldg. AG / UBS Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Novartis AG / Roche PS / Swiss Life Hldg. N / UBS Group AG | Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Julius Baer Group / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Partners Group Hldg. AG / Swissquote Group Hldg. S.A. / UBS Group AG | Nestlé S.A. / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG / Zurich Insurance Group AG | Alcon / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Novartis AG / Straumann Hldg. AG / UBS Group AG | Nestlé S.A. / Roche PS / UBS Group AG | Compagnie Financière Richemont SA / Kühne & Nagel Intl. AG / Lonza Group N / UBS Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
22.06.2026 | 10.08.2026 | 26.08.2026 | 19.04.2027 | 24.11.2026 | 22.05.2026 | 05.06.2026 | 05.06.2026 | 08.06.2026 | 26.05.2026 | 14.06.2027 | 21.12.2026 | 29.06.2026 | 29.06.2026 | 24.06.2026 | 03.07.2026 | 12.06.2026 | 06.07.2026 | 08.07.2026 | 08.07.2026 |
| Demande | 99,01 | 99,01 | 98,59 | 97,72 | 98,41 | 100,23 | 93,60 | 93,90 | 98,61 | 96,12 | 94,88 | 96,42 | 92,25 | 92,15 | 96,85 | 93,75 | 92,10 | 95,13 | 99,15 | 99,58 |
| Offre | 101,01 | 101,01 | - | 99,70 | 100,40 | - | 94,60 | 94,90 | 100,61 | - | 95,68 | 98,39 | 93,25 | 93,15 | - | 94,75 | 93,10 | 97,08 | - | - |